您的购物车当前为空
Prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] is a peptide with the sequence H2N-Ala-Thr-Gly-Gly-Tyr-Arg-OH, MW= 623.66.
![prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens]](https://cdn.targetmol.cn/group3/M00/02/50/CgoaEGY7L3uEc1XbAAAAAD-06FI904.png)
Prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] is a peptide with the sequence H2N-Ala-Thr-Gly-Gly-Tyr-Arg-OH, MW= 623.66.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 483 | 3-6月 | |
| 5 mg | ¥ 1,383 | 3-6月 | |
| 10 mg | ¥ 2,283 | 3-6月 | |
| 25 mg | ¥ 3,183 | 3-6月 |
| 产品描述 | Prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] is a peptide with the sequence H2N-Ala-Thr-Gly-Gly-Tyr-Arg-OH, MW= 623.66. |
| 体外活性 | Prostate apoptosis response-4 (Par-4) is a human gene coding for a tumor-suppressor protein that induces apoptosis in cancer cells, but not in normal cells. The tumor suppressor PAR-4 represses and activates transcription. The protein encoded by this gene is a PAR-4-interacting protein that itself functions as a transcriptional repressor. It contains a putative leucine zipper domain that interacts with the zinc finger DNA binding domain of PAR-4. This protein is specifically upregulated during apoptosis of prostate cells [1]. |
| 体内活性 | The active domain of the Par-4 protein has been found to confer cancer resistance in transgenic mice without compromising normal viability or aging and may have therapeutic significance [2]. |
| 分子量 | 623.66 |
| 分子式 | C26H41N9O9 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: ≥62.3 mg/mL, Sonication is recommended. |
评论内容